+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Slow accommodation release with a cerebellar lesion

Slow accommodation release with a cerebellar lesion

British Journal of Ophthalmology 77(10): 678-678

(PDF emailed within 0-6 h: $19.90)

Accession: 033411973

Download citation: RISBibTeXText

PMID: 8218041

DOI: 10.1136/bjo.77.10.678

Related references

Volitional movement is not preceded by cortical slow negativity in cerebellar dentate lesion in man. Brain Research 368(2): 361-365, 1986

Myorhythmias associated with a cerebellar syndrome, appearing after a lesion of the nuclei of the cerebellum in two cases, and a lesion of the superior cerebellar peduncle in a third case. Rev Neurol [Paris] 109(5): 513-528, 1963

Influence of some factors on the in vitro release velocity of active materials from slow release tablets part 3 release velocity of tetracycline hydro chloride from stored and nonstored slow release tablets. Die Pharmazie 33(4): 212-216, 1978

The conductance underlying the parallel fibre slow EPSP in rat cerebellar Purkinje neurones studied with photolytic release of L-glutamate. Journal of Physiology (Cambridge) 533(3): 765-772, June 15th, 2001

Bioavailability of 3 formulations of pseudo-ephedrine EFIDAC/24, a 24h-slow-release tablet, in comparison with sudafed, an immediate-release tablet, and NASA-12, A 12h-slow-release capsule. Therapie (Paris) 0(SUPPL ): 488, 1995

Influence of the application site on bioadhesion and slow-release characteristics of a bioadhesive buccal slow-release tablet of miconazole. European Journal of Clinical Pharmacology 44(4): 331-335, 1993

Influence of the application site on bioadhesion and slow-release characteristics of a buccal bioadhesive miconazole slow-release tablet. Pharmaceutical Research (New York) 9(10 SUPPL ): S243, 1992

Treatment of idiopathic restless legs syndrome (RLS) with slow-release valproic acid compared with slow-release levodopa/benserazid. Journal of Neurology 251(5): 579-583, 2004

Incidence of cardiac arrhythmias in patients taking slow release salbutamol and slow release terbutaline for asthma. British Medical Journal 288(6414): 367-367, 1984

Laser-ablated nanofunctional polymers for the formulation of slow-release powders for dry powder inhalers: physicochemical characterization and slow-release characteristics. Journal of Pharmacy and Pharmacology 59(11): 1473-1484, 2007

Cardiac effects of slow-release lanreotide, a slow-release somatostatin analog, in acromegalic patients. Journal of Clinical Endocrinology and Metabolism 84(2): 527-532, 1999

Conventional and slow release formulations of nifedipine and verapamil are more effective than slow release isosorbide dinitrate (ISDN) in preventing episodes of angina at rest. European Heart Journal 8(4): 435-436, 1987

Nocturnal asthma: slow-release terbutaline versus slow-release theophylline therapy. European Respiratory Journal 1(4): 306-310, 1988

Double-blind, randomized comparative study of the antihypertensive effect of nicardipine slow-release and nifedipine slow-release in hypertensive patients with coronary heart disease. Cardiovascular Drugs and Therapy 5(3): 647-654, 1991